EGFR and non-small cell lung carcinoma: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are effective treatments for patients with advanced non-small cell lung cancer (NSCLC) harboring an EGFR-TKI sensitizing mutation (EGFRm)1.